Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Enforcement In Brief

This article was originally published in The Tan Sheet

Executive Summary

Perrigo facility undergoes reinspection

Perrigo facility undergoes reinspection

Agency inspectors return to Perrigo's Allegan, Mich., manufacturing plant to follow up on an April 30, 2010, warning letter, the company says March 1. Following remediation, Allegan's output is back to full strength, though the private labeler had anticipated FDA's return to the facility before the end of 2010 (Also see "Perrigo Absorbs Plant Remediation Sales Hit, But PBM Progresses In Q1" - Pink Sheet, 8 Nov, 2010.).

Sibutramine supplement recalled

Svelte 30 Nutritional Consultants voluntarily recalls Svelte 30 orange and gray capsules after FDA notified the firm that the weight-loss products contain sibutramine, an Rx obesity drug ingredient withdrawn from the market after it was found to increase the risk of heart attack and stroke. The recalled lots were sold through the firm's Kissimmee, Fla., sales office on Jan. 3, 2011, but were not sold through the company's website.

FDA cites protein products labels, GMPs

Abba Pharma misbranded products, violated good manufacturing practices, made illegal drug claims and marketed an adulterated supplement, FDA says in a Feb. 9 letter. It cited evidence discovered during an August 2010 inspection. Several of the firm's protein products had higher levels of phosphorous, sodium and potassium than listed. The Tampa, Fla., firm's Nephronex liquid dietary supplement is an adulterated supplement because the firm failed to conduct appropriate batch and identity tests, among other GMP violations. The firm also makes illegal drug claims for Nephronex, Proteinex liquid predigested protein and ProteinexWound Care on labeling and online.

Supplement firms cited for drug claims

Millennium Bioceutics' and Ancient Formulas Inc.'s claims cause supplements to be marketed as drugs, FDA says in letters to the firms. In a Feb. 17 letter FDA says Delray Beach, Fla.-based Millennium makes anti-cancer claims for its Caplex Supplement. A Feb. 9 letter to Wichita, Kan.-based Ancient Formulas notes "labeling is not limited to the immediate product containers but includes all promotional literature which you distribute in connection with your products" and cites illegal claims for 13 products. One of Ancient Formula's products, Dyabet, is misbranded because it does not include capsule ingredients and does not have a supplement facts panel.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel